Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RFESD | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PIGA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PRELID3B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | THAP11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | HBA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CDK5RAP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | SF3A2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | SPACA1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | FBXL4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | KCNH2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |